| 000 | 01175 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250516234043.0 | ||
| 264 | 0 | _c20150831 | |
| 008 | 201508s 0 0 eng d | ||
| 022 | _a1875-533X | ||
| 024 | 7 |
_a10.2174/0929867321666140916123022 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aReinen, J | |
| 245 | 0 | 0 |
_aBiotransformation of endocrine disrupting compounds by selected phase I and phase II enzymes--formation of estrogenic and chemically reactive metabolites by cytochromes P450 and sulfotransferases. _h[electronic resource] |
| 260 |
_bCurrent medicinal chemistry _c2015 |
||
| 300 |
_a500-27 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xmetabolism |
| 650 | 0 | 4 |
_aEndocrine Disruptors _xpharmacokinetics |
| 650 | 0 | 4 |
_aEstrogens _xpharmacokinetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aSulfotransferases _xmetabolism |
| 700 | 1 | _aVermeulen, N P E | |
| 773 | 0 |
_tCurrent medicinal chemistry _gvol. 22 _gno. 4 _gp. 500-27 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/0929867321666140916123022 _zAvailable from publisher's website |
| 999 |
_c24212705 _d24212705 |
||